Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment.
about
Atrial fibrillation in a primary care practice: prevalence and managementProtocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN893A critical appraisal of clinical practice guidelines for the treatment of lower-limb osteoarthritisCritical appraisal of international guidelines for the management of diabetic neuropathy: is there global agreement in the internet era?Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillationMeta-DiSc: a software for meta-analysis of test accuracy data.Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall.The systematic guideline review: method, rationale, and test on chronic heart failure.Implications of applying widely accepted cholesterol screening and management guidelines to a British adult population: cross sectional study of cardiovascular disease and risk factors.The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future.What is the quality of drug therapy clinical practice guidelines in Canada?Barriers to implementing evidence-based clinical guidelines: a survey of early adopters.Differences among international pharyngitis guidelines: not just academic.Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation.Agreement of four competing guidelines on prevention of venous thromboembolism and comparison with observed physician practices: a cross-sectional study of 1,032 medical inpatientsUse of antithrombotic measures for stroke prevention in atrial fibrillation.Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population.A review of guidelines on benign prostatic hyperplasia and lower urinary tract symptoms: are all guidelines the same?A critical review of guidelines for low back pain treatment.Lack of uniformity in levels of evidence and recommendation grades in surgical oncology guidelines.A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation.Strategies to promote prudent antibiotic use: exploring the views of professionals who develop and implement guidelines and interventions.Audit of anticoagulant therapy and acute hospital admissions.Identification of patients with atrial fibrillation in general practice.Clinical practice guidelines: towards better quality guidelines and increased international collaboration.Doctors and patients must decide together whether anticoagulation is appropriate.[Atrial fibrillation, stroke and anticoagulation: under-use of warfarin?].ORBIT score: an useful predictor of small bowel rebleeding in patients under chronic anticoagulation.Evidence-based guidelines: response to professor Gordon Parker's critique.Determining indications for care common to competing guidelines by using classification tree analysis: application to the prevention of venous thromboembolism in medical inpatients.Clinical questions and information needs.Guidelines in cardiac clinical practice: evaluation of their methodological quality using the AGREE II instrument.The Role of Economics in Canadian Clinical Practice Guidelines for Drug Therapy
P2860
Q24795377-9089BE43-AD74-4BC7-A15E-C7890979B062Q24801915-45EC2A64-AA44-4D3D-8AA5-4213DF487B67Q24805955-6ABC7FE0-F78E-41B2-A304-7F365C04B967Q28088761-CEFA5581-34EA-4574-ACCC-928075368B50Q28175307-961315A8-AA69-4C00-8B3F-42E4DE4C03A9Q31048578-B12236B4-E21D-4C77-95D4-96A68132D068Q33239013-7612C267-71B8-42AC-904C-397EFC1E33CEQ33441898-1615A408-DABF-4279-BF47-CEE2464852B5Q33849284-EF112279-D5A9-4F81-826D-6062AC6039CBQ33955304-3732BCC1-298F-4D33-B7B8-7CCEBA083954Q33956167-61E7FFA5-48C3-4060-AC99-F74FD0B9C196Q34447450-B153C58A-311B-4A66-A2A6-642D7F802B0DQ34692681-4CFB742C-005C-4487-95AB-5A2506BB821FQ34700318-ADF5B774-2E21-4CF6-9BF5-96A613748D70Q34733377-E4DE09CA-0C2F-4E92-BC81-6180875D0B00Q35566675-E31CAF01-0FB3-4063-B179-F4005FF109C9Q35583944-008D7385-C816-48E8-812F-79BF1D6B667EQ35591119-01333BED-D62C-4354-9F1D-08305BCF23A0Q36283172-2547B1C7-0BE7-417A-ABAD-DC3D377ABB3EQ36312814-DCC8EE8E-C8CB-4DC5-86B7-0AB7A3749DC4Q37284382-6E72E64A-0EEC-4CE6-9750-7215F156125BQ38635098-0B056506-926C-4FA8-B52D-850AC30D60DFQ39564827-D2E06B4C-4C0C-4001-AFD8-0ECCA04FCFBEQ42042503-571625B4-5D74-4018-A864-0658C9550787Q42141830-759163A7-8757-418F-9B1A-B6249B80BEF6Q42569826-951438FC-2C45-4DC0-8E6E-7EF4FFEF49BFQ42757686-D92E49A9-9493-4504-BCA0-D65545B0F0B8Q45194118-8024E2A5-5E55-4B9F-8366-A96D41AE9372Q47349565-39798B0D-C51F-4015-9837-2D6A86742C66Q51935481-9D214D74-D59B-4609-A53E-D7644F4139F7Q51949430-B2C55024-B4D0-456D-8956-5E5A3C8613B9Q52077667-1C3489B1-1CF3-47F1-9ACB-5531E54005C7Q55312694-C50DC415-4C13-4CB4-826F-91CA788A0964Q57302049-797F78E7-7AB1-41AB-8DA7-3BE96495FCCB
P2860
Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Guidelines on anticoagulant tr ...... nd implications for treatment.
@en
Guidelines on anticoagulant tr ...... nd implications for treatment.
@nl
type
label
Guidelines on anticoagulant tr ...... nd implications for treatment.
@en
Guidelines on anticoagulant tr ...... nd implications for treatment.
@nl
prefLabel
Guidelines on anticoagulant tr ...... nd implications for treatment.
@en
Guidelines on anticoagulant tr ...... nd implications for treatment.
@nl
P2093
P356
P1433
P1476
Guidelines on anticoagulant tr ...... nd implications for treatment.
@en
P2093
P304
P356
10.1136/BMJ.316.7130.509
P407
P577
1998-02-01T00:00:00Z